In conclusion, our studies demonstrated that both PCIF1 and CTBP2 were independent predictors in patients with HNSCC, and patients with increased nuclear expression of PCIF1 and CTBP2 in tumor lesions tended to have an unfavorable prognosis. This evidence concerns the gene PCIF1 and head and neck squamous cell carcinoma.